Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	dependence benzodiazepine receptor agonist anxiolytics hypnotics belief Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/e6fa0737678d4e279fc8f41c81388e66
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e6fa0737678d4e279fc8f41c81388e66
record_format	dspace
spelling	oai:doaj.org-article:e6fa0737678d4e279fc8f41c81388e662021-12-02T17:40:59ZDifferent Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment1178-2021https://doaj.org/article/e6fa0737678d4e279fc8f41c81388e662021-06-01T00:00:00Zhttps://www.dovepress.com/different-attitudes-of-patients-and-psychiatrists-toward-benzodiazepin-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 3Department of Psychiatry, Minato Hospital, Hachinohe, Japan; 4Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan; 5Department of Psychiatry, Aomori Central Hospital, Aomori, Japan; 6Department of Neuropsychiatry, Mutsu General Hospital, Mutsu, Japan; 7Department of Neuropsychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan; 8Department of Psychiatry, Nakagami Mental Clinic, Ohdate, JapanCorrespondence: Norio Yasui-FurukoriDepartment of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, JapanTel +81-28-287-2153Fax +81-28-286-5187Email furukori@dokkyomed.ac.jpBackground: Concern regarding the benefit/risk ratio of the long-term use of benzodiazepines (BDZs) and Z-drugs is increasing. To prevent the risk of dependence in BDZ long-term use, it is essential to understand the attitudes of patients and psychiatrists toward BDZ treatment. The aims of this investigation were to 1) obtain information on patients’ attitudes with long-term BDZ use and their referring psychiatrists’ attitudes toward BDZ treatment, including their perception of the difficulty of reducing the dose of BDZs, and 2) identify discrepancies between patients’ and psychiatrists’ perceptions.Methods: A brief questionnaire was constructed to investigate the attitudes of patients receiving BDZ treatment and their referring psychiatrists. Our sample comprised 155 patients who received BDZ treatment for more than one year and their referring eight psychiatrists. Both the patients and their psychiatrists completed our questionnaire between August 2017 and December 2017.Results: Of the patients, 13% felt that it was more difficult to reduce the dose of BDZs than their referring psychiatrists (type A discrepancy), while 25% felt that it was less difficult (type B discrepancy). In the multivariate logistic regression analysis, the female sex and both the patients’ (“psychotherapy plus BDZs was necessary” and “it was necessary to increase the dose of BDZs”) and psychiatrists’ beliefs (“short-term prescription was justified”) were associated with type A discrepancies. Type B discrepancies were associated with psychiatrists’ beliefs that the patient’s wishes justified the use of BDZs and that the cessation of treatment with BDZs would lead to the deterioration of their rapport with their patients.Conclusion: To overcome the discrepancies in the attitudes of patients and psychiatrists toward the cessation of BDZ treatment, it is necessary to promote patient-centered care involving patient psychoeducation and practice guidelines for the decision-making process. Further studies investigating the promotion of patient-centered care to reduce BDZ use are needed.Keywords: dependence, benzodiazepine receptor agonist, anxiolytics, hypnotics, beliefKawamata YSugawara NIshioka MKubo KSuzuki KFujii AFurukori HNakagami TYasui-Furukori NShimoda KDove Medical Pressarticledependencebenzodiazepine receptor agonistanxiolyticshypnoticsbeliefNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 1927-1936 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	dependence benzodiazepine receptor agonist anxiolytics hypnotics belief Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	dependence benzodiazepine receptor agonist anxiolytics hypnotics belief Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Kawamata Y Sugawara N Ishioka M Kubo K Suzuki K Fujii A Furukori H Nakagami T Yasui-Furukori N Shimoda K Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
description	Yasushi Kawamata,1 Norio Sugawara,1,2 Masamichi Ishioka,3 Kazutoshi Kubo,4 Katsuji Suzuki,5 Akira Fujii,6 Hanako Furukori,7 Taku Nakagami,8 Norio Yasui-Furukori,1,2 Kazutaka Shimoda1 1Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan; 2Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan; 3Department of Psychiatry, Minato Hospital, Hachinohe, Japan; 4Department of Neuropsychiatry, Hirosaki-Aiseikai Hospital, Hirosaki, Japan; 5Department of Psychiatry, Aomori Central Hospital, Aomori, Japan; 6Department of Neuropsychiatry, Mutsu General Hospital, Mutsu, Japan; 7Department of Neuropsychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan; 8Department of Psychiatry, Nakagami Mental Clinic, Ohdate, JapanCorrespondence: Norio Yasui-FurukoriDepartment of Psychiatry, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, JapanTel +81-28-287-2153Fax +81-28-286-5187Email furukori@dokkyomed.ac.jpBackground: Concern regarding the benefit/risk ratio of the long-term use of benzodiazepines (BDZs) and Z-drugs is increasing. To prevent the risk of dependence in BDZ long-term use, it is essential to understand the attitudes of patients and psychiatrists toward BDZ treatment. The aims of this investigation were to 1) obtain information on patients’ attitudes with long-term BDZ use and their referring psychiatrists’ attitudes toward BDZ treatment, including their perception of the difficulty of reducing the dose of BDZs, and 2) identify discrepancies between patients’ and psychiatrists’ perceptions.Methods: A brief questionnaire was constructed to investigate the attitudes of patients receiving BDZ treatment and their referring psychiatrists. Our sample comprised 155 patients who received BDZ treatment for more than one year and their referring eight psychiatrists. Both the patients and their psychiatrists completed our questionnaire between August 2017 and December 2017.Results: Of the patients, 13% felt that it was more difficult to reduce the dose of BDZs than their referring psychiatrists (type A discrepancy), while 25% felt that it was less difficult (type B discrepancy). In the multivariate logistic regression analysis, the female sex and both the patients’ (“psychotherapy plus BDZs was necessary” and “it was necessary to increase the dose of BDZs”) and psychiatrists’ beliefs (“short-term prescription was justified”) were associated with type A discrepancies. Type B discrepancies were associated with psychiatrists’ beliefs that the patient’s wishes justified the use of BDZs and that the cessation of treatment with BDZs would lead to the deterioration of their rapport with their patients.Conclusion: To overcome the discrepancies in the attitudes of patients and psychiatrists toward the cessation of BDZ treatment, it is necessary to promote patient-centered care involving patient psychoeducation and practice guidelines for the decision-making process. Further studies investigating the promotion of patient-centered care to reduce BDZ use are needed.Keywords: dependence, benzodiazepine receptor agonist, anxiolytics, hypnotics, belief
format	article
author	Kawamata Y Sugawara N Ishioka M Kubo K Suzuki K Fujii A Furukori H Nakagami T Yasui-Furukori N Shimoda K
author_facet	Kawamata Y Sugawara N Ishioka M Kubo K Suzuki K Fujii A Furukori H Nakagami T Yasui-Furukori N Shimoda K
author_sort	Kawamata Y
title	Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_short	Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_full	Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_fullStr	Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_full_unstemmed	Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
title_sort	different attitudes of patients and psychiatrists toward benzodiazepine treatment
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/e6fa0737678d4e279fc8f41c81388e66
work_keys_str_mv	AT kawamatay differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT sugawaran differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT ishiokam differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT kubok differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT suzukik differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT fujiia differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT furukorih differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT nakagamit differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT yasuifurukorin differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment AT shimodak differentattitudesofpatientsandpsychiatriststowardbenzodiazepinetreatment
_version_	1718379735441997824

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Ejemplares similares